Doctor Karan Bami
St. Michael's Hospital, Toronto (Canada)
Effects of empagliflozin on cardiac function in patients with type 2 diabetes mellitus: echocardiographic substudy of the EMPA-HEART cardiolink-6 trial
Event: ESC Congress 2019
Topic: Systolic and Diastolic Function
Session: Echo cardiomyopathy
ESC 365 is supported by
